Sabra Healthcare REIT stockSBRA
Sabra Healthcare REIT trades at $20.89, 8.3% below its 52-week high (Jul 28, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +13.6% year to date, +20.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 23, 2027.
Ratings, candles, signals and the screener for SBRA — after you log in
Open the terminalFrequently asked questions about Sabra Healthcare REIT
What is the Sabra Healthcare REIT stock price?
At the close on Nov 5, 2026: $20.89 (−0.95% on the day). 52-week high: $22.77 on Jul 28, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Sabra Healthcare REIT report earnings?
The next quarterly report is on Feb 23, 2027. Last quarter, earnings per share changed +8% year over year, revenue +31%.
Does Sabra Healthcare REIT pay dividends?
Yes, the dividend yield is about 6.08% a year.
Where does Sabra Healthcare REIT trade and how to buy it?
Ticker SBRA, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Sabra Healthcare REIT now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for SBRA are in the terminal after you log in.